Suboxone Tooth Decay / Dental Injury MDL
Suboxone tooth decay and dental injury MDL - newly consolidated
Recent signals
- CL filing: Fas-Tes Franchise Systems, LLC v. Ramsey Diagnostics Corp.
- CL filing: Billy F. Steffey v. United States of America
- Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I
- 261008 ASH memo to DEA- Recommendation on 7-OH thresholding- 712892 ASH signed- UPDATED
- Ban on Suboxone use for ‘safety-sensitive’ roles draws EEOC lawsuit - Yahoo
- CL filing: AMERICAN HOSPITAL ASSOCIATION v. KENNEDY
- Reference 5 - Kock, P., Froelich, K., Walter, M., Lang, U., and K.M. Du¨ rsteler, ‘‘A systematic literature review of clinical trials and therapeutic applications of ibogaine,’’ J. Subst. Abuse Treat., 138:108717 (2022), available at doi:10.1016/j.jsat.2021.108717.
- Reference 1 - Alper, K.R., Stajic´, M., and J.R. Gill, ‘‘Fatalities temporally associated with the ingestion of ibogaine,’’ J. Forensic Sci., 57(2):398–412 (2012), available at doi:10.1111/j.1556-4029.2011.02008.x.
- Reference 3 - Knuijver, T., Schellekens, A., Belgers, M., Donders, R., van Oosteren, T., et al., ‘‘Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study,’’ Addiction, 117(1):118–128 (2022), available at doi:10.1111/add.15448
- Reference 4 - Knuijver, T., ter Heine, R., Schellekens, A.F.A., Heydari, P., Lucas, L., et al., ‘‘The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients,’’ J. Psychopharmacol., 38(5):481–488 (2024), available at doi:10.1177/02698811241237873.
Products: suboxonebuprenorphinenaloxonesublingual film
Frequently asked questions
Who qualifies for the Suboxone Tooth Decay / Dental Injury MDL case?
You may qualify if the following applies to you: Used Suboxone sublingual films for at least six months and experienced severe tooth decay, dental erosion, or tooth loss. Eligibility criteria can change as the case develops.
How much could a Suboxone Tooth Decay / Dental Injury MDL claim be worth?
Estimated payouts range from $5,000 to $150,000 depending on individual circumstances. These are estimates based on comparable outcomes, not guarantees.
What is the current status of the Suboxone Tooth Decay / Dental Injury MDL case?
In litigation. Indivior's Suboxone sublingual films have been alleged to cause severe tooth decay, dental erosion, and tooth loss due to extended oral contact with the medication's acidic compounds. MDL No. 3092 was consolidated in the Northern District of Ohio in 2024. Suboxone is used for opioid use disorder treatment, so plaintiffs are typically long-term medication-assisted treatment patients.
How do I check whether I'm included?
Take the free 30-second audit at https://getclaimscout.com/audit and claimscout matches the brands and products you've used against every active class action settlements and mass torts it tracks, or review the eligibility details at https://getclaimscout.com/matters/suboxone-tooth-decay.
Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.
On iPhone? Get the Claimscout app and follow this settlement for updates.